SCNI

#5247
Scinai Immunotherapeutics Ltd - American Depositary Shares
0.0 0 USD
+2.27%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
0.00
0.00
Faixa anual
0.00
1.05
Mudança diária
+2.27%
Mudança mensal
-99.36%
Mudança em 6 meses
-99.40%
Mudança anual
-99.40%
Fechamento anterior
0.0 0
Open
0.0 0
Mínimo
0.0 0
High
0.0 0
Volume
3
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 15.61 K
  • Employee 45
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
791.22
Índice preço/fluxo de caixa
5 072.94

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Notícias